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Mahnaz Kazemi1, Azadeh Eshraghi2, Afsaneh Yegdaneh1 and Alireza Ghannadi1*Pharmacy is known as a branch related to healthcare ser-
vices [1]. According to the features of pharmacognosy
and clinical pharmacy two distinctive and important sub-
jects of pharmacy in this editorial it has been introduced
as a new integrated and multidisciplinary feature between
these two subjects named; “clinical pharmacognosy”.
Pharmacognosy, which literally means studying medi-
cations of natural sources, has been a part of medical
arts and sciences since mankind first began to treat ill-
nesses [2]. To get a proper perspective about this
science, which deals with plant, animal, mineral and
other natural medications, it is extremely helpful to
investigate the historical aspects of this science and to
recognize the pioneers of this field. By an experience
obtained from trial and error, early man had to acquire
biologic knowledge useful in determining the effects of
available foods and beverages derived from plants.
Although the pharmacognosy term was used for the first
time in 1811 by the Austrian physician, Schimdt, the
founder of the first independent pharmacognosy insti-
tute in the world was Crovatian Domac in 1896 [2-4]. In
the field of pharmacognosy the Persian outstanding
scientists like Rhazes, Avicenna and Jorjani created major
progresses and improvements that started modern
pharmacognosy in the world. Fortunately traditional
medicine and its remedies contribute to a major role in
the current health care systems of several countries [4,5].
The study of medications of plant origin includes the
subjects of botany, chemistry and pharmacology. Botany
includes toxonomy, genetics, and cultivation of plants.
Chemical characterization includes the isolation, eluci-
dation and quantification of constituents and natural
products pharmacology. The science of pharmacognosy
has been progressed to phytochemistry, plant bio-
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reproduction in any medium, provided the orphytotherapy, marine and zoo pharmacognosy. Although
pharmacognosy has been improved and expanded in
several aspects, it has no hard link with clinical trials
yet [2,5].
Clinical pharmacy requires optimum use of medica-
tions, therapeutic knowledge, counseling, clinical experi-
ence, therapeutic drug monitoring and disease good
diagnosis. A clinical pharmacist collaborates with physi-
cians in multidisciplinary meetings and rounds and
would advise regarding the cost-effectiveness, safety
and appropriateness of medications. Clinical pharmacists
should monitor patient outcomes according to the
patient’s situation and the probable risks associated with
therapy. Recognition of therapeutic systems and patient
records are principles of this field. Clinical pharmacists
should prepare a nice atmosphere and consultation area
and have a good communication skill as well as should
know the patient’s quality of life that can be obtained via
interview of patients [1,6,7]. Also the clinical pharmacist
should be aware of disease etiology, drug allergies,
drug interactions and patient monitoring to choose the
rational drug and regimen. Therefore the clinical phar-
macist should know to detect and document adverse
reactions to recommend selecting better choice [1,7].
While clinical pharmacy significantly progressed, a gap
between this science and herbal and traditional medi-
cines fields is evident. As the use of herbals increased
in the recent years, new kinds of demands are raised.
There are several potential problems associated with
herbal remedies like lacking of systematic reviews and
evidence-based data about their efficacies [1,2,5,7]. There
are a few systematic reviews about traditional Iranian
medicine [8-12].
One of the reasons behind increase in use of herbal
medicines is the belief that they have lower toxicities but
the fact is that herbal medicines may cause unwanted
effects, allergic or toxic reactions [2,5,13]. Herbs can
even cause drug-drug, drug-food and herb-drug interac-
tions if not properly used specially in use of OTC drugs
[5,13,14].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kazemi et al. DARU Journal of Pharmaceutical Sciences 2012, 20:18 Page 2 of 3
http://www.darujps.com/content/20/1/18Clinical pharmacognosy should deal with above pro-
blems and find the best solutions for them. Although
this term has been used in a workshop in the United
States entitled, “Clinical Pharmacognosy: Contribution
of pharmacognosy to clinical trials of botanicals and
dietary supplements”, which took place at the American
Society of Pharmacognosy meeting in Portland, Maine,
on July 2007 and in a Japanese journal on March 2011,
there has not been any comprehensive definition yet
[15,16]. The renaissance of herbal medicine in the world
creates a demand for studies in the field of pharma-
cognosy, traditional medicine and some related fields.
From a practical perspective this includes quality control
(identity, purity, consistency), efficacy (therapeutic indi-
cations, clinical studies, pharmacological investigations),
documentation and safety (adverse reactions, drug inter-
actions, contraindications, precautions and toxicities).
There are huge capacities of research topics in the
herbal and traditional medicine fields which this new
discipline can design and perform them clinically. This
new borderline discipline may extend the scope of clin-
ical aspects of pharmacognosy and play a progressive
role in the safe, rational and efficient use of traditional
and herbal medicine. There are several unproven thera-
peutic benefits and undisclosed toxicities and difficulties
in standardizing natural treatments [2,13-16]. Clinical
pharmacognosy is a bridge between clinical research and
botanicals knowledge providing clinical and pharmaceut-
ical researchers, physicians and other healthcare profes-
sionals with the key information they need to assist the
progress of herbal and traditional medicines. Clinical
pharmacognosist should ask the patients about the
herbal drugs or other supplements they have had taken
before and about the history of possible allergic reac-
tions. He should also evaluate the patient recovery
process after using each kind of synthetic, herbal or
traditional drugs and should focus on resolving a wide
range of challenging problems [8,11,12,15,16].
It seems that in the third millennium, we need educa-
tion of clinical pharmacognosists for providing more
details regarding different aspects of clinical applications
of natural health products. In order to use rational
herbal and traditional medicines and adding standard
clinical values to them, establishing and spreading of
clinical pharmacognosy feature may help to improve
health to all. Clinical pharmacognosist can provide
full and correct information about all pharmaceutical
and medical aspects of plants, natural health products
and dietary supplements. This field may plays leading
and interesting roles in identifying, analyzing, standard-
izing, controlling, documentation and determining of
these natural health products evidence based medicines.
It increases more the findings of effective naturals
especially by doing systematic review of randomizedcontrolled trials evaluated herbal therapies for different
diseases [2,5,14-16]. For instance, a recent systematic re-
view in traditional Iranian medicine (TIM) opened a
new era in the field of inflammatory bowel disease and
has introduced new research lines [17]. Interestingly, in
TIM, name of diseases or even herbal compounds have
some differences with the present names and terms;
so researchers must be so careful to study TIM and
translate it into current language. New attention to these
effective herbs will lead us to discovery and obtaining
novel natural drugs.
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